Matthew W Foehr sold $562K of Viking Therapeutics (VKTX)

Executed Jan 2, disclosed Jan 5, 3 days later.

Value, as filed

$562K

16,000 sh × $35.11

Executed

Jan 2

the trade date, as filed

Disclosed

Jan 5

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MF Matthew W Foehr President and CEO profile →

Matthew W Foehr (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in OABI. The largest single filing was $562K of VKTX (16,000 sh × $35.11, as filed), executed Jan 2.

The name

VKTX

Viking Therapeutics, Inc. VKTX · Healthcare · 22 filings in 24 months ticker →

Healthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→